Skip to content

Clinical trials

Completed Pulmonary Arterial Hypertension trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Status: Completed Country / region: China Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20072
20083
20092
20101
20112
20121
20133
20171
20182
20193
20201
20212
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion9
United Therapeutics5
Vigonvita Life Sciences4
Bayer2
Chinese Academy of Medical Sciences, Fuwai Hospital1
Imperial College London1
Merck Sharp & Dohme LLC1
Nanjing First Hospital, Nanjing Medical University1
Pfizer1
Pfizer Pharmaceuticals Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension28
Hypertension, Pulmonary8
Erectile Dysfunction2
Familial Primary Pulmonary Hypertension2
Cardiovascular Diseases1
Connective Tissue Diseases1
Eisenmenger Complex1
Heart Failure1
Hypertension1
Iron Deficiencies1

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.